Related references
Note: Only part of the references are listed.Progress on Modulating Tumor-Associated Macrophages with Biomaterials
Meilyn Sylvestre et al.
ADVANCED MATERIALS (2020)
Immune-Related Adverse Events by Immune Checkpoint Inhibitors Significantly Predict Durable Efficacy Even in Responders with Advanced Non-Small Cell Lung Cancer
Hiroaki Akamatsu et al.
ONCOLOGIST (2020)
Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
Dongbo Li et al.
CANCER SCIENCE (2020)
Siglec-10 expression is up-regulated in activated human CD4+ T cells
E. Bandala-Sanchez et al.
HUMAN IMMUNOLOGY (2020)
Combination of CD47 and signal-regulatory protein-α constituting the don't eat me signal is a prognostic factor in diffuse large B-cell lymphoma
Ryo Kazama et al.
CANCER SCIENCE (2020)
Research progress of tumor microenvironment and tumor-associated macrophages
W. Liang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Relationship between STK11 and KEAP1 mutational status and efficacy in KEYNOTE-042: pembrolizumab monotherapy versus platinum-based chemotherapy as first-line therapy for PD-L1-positive advanced NSCLC
Byoung Chul Cho et al.
CANCER RESEARCH (2020)
Predictive value of serum protein levels in patients with advanced non-small cell lung cancer treated with nivolumab
Jun Oyanagi et al.
LUNG CANCER (2019)
Association of STK11/LKB1 genomic alterations with lack of benefit from the addition of pembrolizumab to platinum doublet chemotherapy in non-squamous non-small cell lung cancer.
Ferdinandos Skoulidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients
Jing Chen et al.
ONCOIMMUNOLOGY (2019)
Overview of CD24 as a new molecular marker in ovarian cancer
Vahideh Tarhriz et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis
Martha Gschwandtner et al.
FRONTIERS IN IMMUNOLOGY (2019)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Siglec-G represses DAMP-mediated effects on T cells
Tomomi Toubai et al.
JCI INSIGHT (2017)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
Hui Zhao et al.
SCIENTIFIC REPORTS (2016)
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
K. Abiko et al.
BRITISH JOURNAL OF CANCER (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation
Selma Rivas-Fuentes et al.
JOURNAL OF CANCER (2015)
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
Roberto Bellucci et al.
ONCOIMMUNOLOGY (2015)
Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients
Michael Majores et al.
BMC CLINICAL PATHOLOGY (2015)
Siglec-mediated regulation of immune cell function in disease
Matthew S. Macauley et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Recruitment of a Myeloid Cell Subset (CD11b/Gr1mid) via CCL2/CCR2 Promotes the Development of Colorectal Cancer Liver Metastasis
Lei Zhao et al.
HEPATOLOGY (2013)
Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
Shaherin Basith et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
Importance of chemokine (CC-motif) ligand 2 in breast cancer
Jennifer L. Steiner et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
CD47 applies the brakes to angiogenesis via vascular endothelial growth factor receptor-2
Sukhbir Kaur et al.
CELL CYCLE (2011)
Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone
Xin Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
Guo-Yun Chen et al.
SCIENCE (2009)
Functions and molecular mechanisms of the CD47-SIRPα signalling pathway
Takashi Matozaki et al.
TRENDS IN CELL BIOLOGY (2009)
Inhibition of self engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
Richard K. Tsai et al.
JOURNAL OF CELL BIOLOGY (2008)
Phagocytosis and antigen presentation in dendritic cells
Ariel Savina et al.
IMMUNOLOGICAL REVIEWS (2007)
Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Publication with Expression of Concern. See vol. 79, pg. 4305, 2019)
B Huang et al.
CANCER RESEARCH (2005)
Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses
SC Liang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Role of CD47 as a marker of self on red blood cells
PA Oldenborg et al.
SCIENCE (2000)
Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines
DA Arenberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Share Paper
